论文部分内容阅读
目的 :总结瘫速康治疗缺血性脑血管病的临床分析。方法 :1994年 6月～ 2 0 0 0年 6月对 76 0例脑梗塞病人 ,随机分为治疗组 42 0例 ,对照组 340例 ,治疗组男 2 88例 ,女 132例 ,平均年龄 6 2 5岁 ,中医辩证分型 ,中经络 374例 ,中脏腑 46例 ,均以瘫速康治疗 ,结果基本治愈 15 2例 ( 36 2 % ) ,显著进步 184例 ( 4 3 8% ) ,进步 74例 ( 17 6 % ) ,无效 10例 ( 2 4% ) ,总有效率97 6 %。结论 :此系列药物治疗缺血性脑血管病 ,能有效改善微循环 ,增加脑血流量 ,清除氧自由基 ,降低血液粘稠度 ,抑制德检形成 ,消除血管阻塞促进渗出吸收 ,正确的辩证 ,合理的应用瘫速康系列药物是治疗缺血性脑血管病成功的关键。
OBJECTIVE: To summarize the clinical analysis of “Parakukang” in the treatment of ischemic cerebrovascular disease. Methods: From June 1994 to June 2000, 760 patients with cerebral infarction were randomly divided into treatment group (42 0 cases) and control group (340 cases). The treatment group consisted of 2 88 males and 132 females with an average age of 6 25 years old, dialectical type of traditional Chinese medicine, 374 cases of meridian and 46 cases of middle-organs were treated with Shengkukang. Results Fifty-two (36.2%) were cured and 184 cases (438%) were significantly improved 74 cases (17 6%) and 10 cases (24%) ineffective with a total effective rate of 97.6%. Conclusion: This series of drugs for the treatment of ischemic cerebrovascular disease, can effectively improve microcirculation, increase cerebral blood flow, scavenge oxygen free radicals, reduce blood viscosity, inhibit German test formation, eliminate vascular obstruction and promote exudate absorption, the correct Dialectical and rational application of Speedy Kang series of drugs is the key to the success of the treatment of ischemic cerebrovascular disease.